Leandro Jonata Oliveira, Medical Oncologist at Grupo Oncoclinicas, shared a poll on X:

“Tapestry Study: screening using exome Sequencing identified 32% of HBOC and 56% of Lynch Syndrome carriers who did not meet NCCN criteria for genetic testing (GT).

In the scenario of unrestricted access to GT and couseling, would you recommend universal germline GT for patients with cancer?

Yes
Not
Not yet

‘Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations published in JCO Precision Oncology’

Autors: N. Jewel Samadder, Emily Gay, Vanda Lindpere, Michelle L. Bublitz, Lorelei A. Bandel, Sebastian M. Armasu, Robert A. Vierkant, Matthew J. Ferber, Eric W. Klee, Nicholas B. Larson, Teresa M. Kruisselbrink, Jan B. Egan, Jennifer L. Kemppainen, Jessa S. Bidwell, Jennifer L. Anderson, Tammy M. McAllister, T’Nita S. Walker, Katie L. Kunze, Michael A. Golafshar, Margaret A. Klint, Richard J. Presutti, William V. Bobo, Aleksander Sekulic, Jolene M. Summer-Bolster, Cheryl L. Willman, and Konstantinos N. Lazaridis.”

Leandro Jonata Oliveira

Source: Leandro Jonata Oliveira/X

Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?

‘Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations published in JCO Precision Oncology’